View Author
stent patient lesion follow-up study month vessel restenosi group trial artery strut implantation analysis scaffold diameter angiographic result table infarction event segment procedure treatment outcome circulation serruy baseline 6 months target everolimus-eluting death intervention revascularization stent thrombosis change ultrasound signi in-stent restenosis lumen value thrombosis in-stent disease paclitaxel-eluting everolimu cardiol sirolimus-eluting randomized stenosi 2 years percutaneou neointimal difference length device cardiology serruys pw heart 12 months ses implantation curvature intravascular figure spirit balloon diabetes mellitus system angiography paclitaxel-eluting stents rotterdam abbott angulation sirolimus-eluting stent implantation 6- month follow-up drug-eluting angioplasty imaging stenting hospital
10 Most Recent Publications
|
Do we have a future with transcatheter adventitial delivery of stem cells?
(Article)
Kharlamov, A.N. Duckers, H.J. Beusekom, H.M.M. van Smits, P.C. Perin, E.C. Serruys, P.W.J.C. |
2012-12-05
|
|
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography
(Article)
Gomez-Lara, J. Brugaletta, S. Dudek, D. Smits, P.C. Chevalier, B. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Farooq, V. Onuma, Y. Diletti, R. Windecker, S. Thuesen, L. McClean, D. Koolen, J. Whitbourn, R. |
2011-12-01
|
|
Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12 months after implantation: Insights from the ABSORB B trial
(Article)
Brugaletta, S. Gomez-Lara, J. Windecker, S. Smits, P.C. Bruyne, B. de Whitbourn, R. Meredith, I. Domburg, R.T. van Sihan, K. Winter, S. de Veldhof, S. Miquel-Hébert, K. Serruys, P.W.J.C. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Bruining, N. Farooq, V. Geuns, R-J.M. van Thuesen, L. Dudek, D. Koolen, J. Chevalier, B. McClean, D. |
2011-12-01
|
|
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents: Pooled analysis from the SPIRIT (Clinical evaluation of the XIENCE v everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials
(Article)
Claessen, B.E. Smits, P.C. Sood, P. Simonton, C. Stone, G.W. Kereiakes, D.J. Parise, H. Fahy, M. Kedhi, E. Serruys, P.W.J.C. Lansky, A.J. Cristea, E. Sudhir, K. |
2011-11-01
|
|
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de Novo Coronary Artery stenosis: 12-month clinical and imaging outcomes
(Article)
Serruys, P.W.J.C. Onuma, Y. Windecker, S. Whitbourn, R. Meredith, I. Dorange, C. Veldhof, S. Hebert, K.M. Sudhir, K. Garcia-Garcia, H.M. Ormiston, J.A. Dudek, D. Smits, P.C. Koolen, J. Chevalier, B. Bruyne, B. de Thuesen, L. McClean, D. Geuns, R-J.M. van |
2011-10-04
|
|
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: Pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE v Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trials
(Article)
Planer, D. Smits, P.C. Kereiakes, D.J. Kedhi, E. Fahy, M. Xu, K. Serruys, P.W.J.C. Stone, G.W. |
2011-10-01
|
|
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography
(Article)
Gomez-Lara, J. Radu, M. Whitbourn, R. Dudek, D. Smits, P.C. Regar, E.S. Veldhof, S. Rapoza, R. Ormiston, J.A. Garcia-Garcia, H.M. Serruys, P.W.J.C. Brugaletta, S. Farooq, V. Diletti, R. Onuma, Y. Windecker, S. Thuesen, L. McClean, D. Koolen, J. |
2011-09-01
|
|
Differential clinical responses to everolimus-eluting and paclitaxel-eluting coronary stents in patients with and without diabetes mellitus
(Article)
Stone, G.W. Kedhi, E. Kereiakes, D.J. Parise, H. Fahy, M. Serruys, P.W.J.C. Smits, P.C. |
2011-08-23
|
|
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm
(Article)
Diletti, R. Onuma, Y. Chevalier, B. McClean, D. Windecker, S. Whitbourn, R. Smits, P.C. Koolen, J. Meredith, I. Li, D. Veldhof, S. Rapoza, R. Farooq, V. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Gomez-Lara, J. Brugaletta, S. Geuns, R-J.M. van Regar, E.S. Bruyne, B. de Dudek, D. Thuesen, L. |
2011-07-12
|
|
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up
(Article)
Gomez-Lara, J. Brugaletta, S. Whitbourn, R. Smits, P.C. Chevalier, B. Morel, M-A.M. Dorange, C. Veldhof, S. Rapoza, R. Garcia-Garcia, H.M. Ormiston, J.A. Serruys, P.W.J.C. Farooq, V. Geuns, R-J.M. van Bruyne, B. de Windecker, S. McClean, D. Thuesen, L. Dudek, D. Koolen, J. |
2011-07-01
|
